sAPPα rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
J. Neurochem. (2012) 122, 208–220. The amyloid precursor protein (APP) is thought to be neuroprotective following traumatic brain injury (TBI), although definitive evidence at moderate to severe levels of injury is lacking. In the current study, we investigated histological and functional outcomes in APP−/− mice compared with APP+/+ mice following a moderate focal injury, and whether administration of sAPPα restored the outcomes in knockout animals back to the wildtype state. Following moderate controlled cortical impact injury, APP−/− mice demonstrated greater impairment in motor and cognitive outcome as determined by the ledged beam and Barnes Maze tests respectively (p < 0.05). This corresponded with the degree of neuronal damage, with APP−/− mice having significantly greater lesion volume (25.0 ± 1.6 vs. 20.3 ± 1.6%, p < 0.01) and hippocampal damage, with less remaining CA neurons (839 ± 245 vs. 1353 ± 142 and 1401 ± 263). This was also associated with an impaired neuroreparative response, with decreased GAP‐43 immunoreactivity within the cortex around the lesion edge compared with APP+/+ mice. The deficits observed in the APP−/− mice related to a lack of sAPPα, as treatment with exogenously added sAPPα post‐injury improved APP−/− mice histological and functional outcome to the point that they were no longer significantly different to APP+/+ mice (p < 0.05). This study shows that endogenous APP is potentially protective at moderate levels of TBI, and that this neuroprotective activity is related to the presence of sAPPα. Importantly, it indicates that the mechanism of action of exogenously added sAPPα is independent of the presence of endogenous APP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury
McKee, A. C., Cantu, R. C., Nowinski, C. J., Hedley-Whyte, E. T., Gavett, B. E., Budson, A. E., Santini, V. E., Lee, H.-S., Kubilus, C. A., & Stern, R. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a9d503 · Cited by 2,295
The impact of traumatic brain injuries: A global perspective
Hyder, A. A., Wunderlich, C. A., Puvanachandra, P., Gururaj, G., & Kobusingye, O. C. (2007) · Neurorehabilitation · doi:10.3233/nre-2007-22502 · Cited by 1,816
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
Mattson, M. P. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1081 · Cited by 1,006
Rates and risk factors for dementia and Alzheimer’s disease: Results from EURODEM pooled analyses
Launer, L. J., Andersen, K., Dewey, M. E., Letenneur, L., Ott, A., Amaducci, L. A., Brayne, C., Copeland, J. R. M., Dartigues, J.-F., Kragh-Sorensen, P., et al. (1999) · Neurology · doi:10.1212/wnl.52.1.78 · Cited by 758
Fleminger, S. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.857 · Cited by 719
Gavett, B. E., Stern, R. A., & McKee, A. C. (2011) · Clinics in Sports Medicine · doi:10.1016/j.csm.2010.09.007 · Cited by 696
TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy
McKee, A. C., Gavett, B. E., Stern, R. A., Nowinski, C. J., Cantu, R. C., Kowall, N. W., Perl, D. P., Hedley-Whyte, E. T., Price, B., Sullivan, C., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ee7d85 · Cited by 659
Mortimer, J. A., Van Duijn, C. M., Chandra, V, Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Rocca, W. A., et al. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.supplement_2.s28 · Cited by 594
Mayeux, R., Ottman, R., Maestre, G., Ngai, C., Tang, M.-X., Ginsberg, H., Chun, M., Tycko, B., & Shelanski, M. (1995) · Neurology · doi:10.1212/wnl.45.3.555 · Cited by 590
Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?
Johnson, V. E., Stewart, W., & Smith, D. H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2808 · Cited by 587 · cited 1×
“Indeed it has been proposed that ongoing axonal injury allows the continued generation of Ab peptides (Johnson et al. 2010), with long-term progressive axonal degeneration and intra-axonal Ab accu- mulation found to persist for years following the initial trauma in humans (Chen et al. 2009).”
BackgroundKamal, A., Almenar-Queralt, A., LeBlanc, J. F., Roberts, E. A., & Goldstein, L. S. B. (2001) · Nature · doi:10.1038/414643a · Cited by 583 · cited 2×
“Damaged axons are thought to be a key source of Ab generation following TBI, as they allow longterm pathological co-localisation of APP with the b-secretase, BACE-1, and the c-secretase, PS1, assisting in a shift towards amyloidogenic processing (Smith et al. 1999; Kamal et al. 2001; Uryu et al. 2007).”
BackgroundHead injury and the risk of AD in the MIRAGE study
Guo, Z., Cupples, L. A., Kurz, A., Auerbach, S. H., Volicer, L., Chui, H., Green, R. C., Sadovnick, A. D., Duara, R., DeCarli, C., et al. (2000) · Neurology · doi:10.1212/wnl.54.6.1316 · Cited by 506 · cited 2×
“This supposition is yet to be conclusively proven with contradictory epidemiological reports on whether a positive association exists between a history of TBI and AD (Guo et al. 2000; Rasmusson et al., 1995; Launer et al. 1999; Fratiglioni et al. 1993).”
BackgroundResultAlzheimer's pathology in human temporal cortex surgically excised after severe brain injury
Ikonomovic, M. D., Uryu, K., Abrahamson, E. E., Ciallella, J. R., Trojanowski, J. Q., Lee, V. M.-Y., Clark, R. S., Marion, D. W., Wisniewski, S. R., & DeKosky, S. T. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.06.011 · Cited by 399
Ring, S., Weyer, S. W., Kilian, S. B., Waldron, E., Pietrzik, C. U., Filippov, M. A., Herms, J., Buchholz, C., Eckman, C. B., Korte, M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1026-07.2007 · Cited by 390 · cited 3×
“However in vivo, knock-in of sAPPa was sufficient to mediate the postnatal physiological actions of APP in APP)/) mice (Ring et al. 2007).”
BackgroundMethodInfluentialUryu, K., Chen, X.-H., Martinez, D., Browne, K. D., Johnson, V. E., Graham, D. I., Lee, V. M.-Y., Trojanowski, J. Q., & Smith, D. H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.018 · Cited by 360
Risk factors for late‐ onset Alzheimer's disease: A population‐ based, case‐control study
Fratiglioni, L., Ahlbom, A., Viitanen, M., & Winblad, B. (1993) · Annals of Neurology · doi:10.1002/ana.410330306 · Cited by 298
Smith, D. H., Chen, X.-H., Nonaka, M., Trojanowski, J. Q., Lee, V.-Y., Saatman, K. E., Leoni, M. J., Xu, B.-N., Wolf, J. A., & Meaney, D. F. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199909000-00008 · Cited by 260
Young-Pearse, T. L., Chen, A. C., Chang, R., Marquez, C., & Selkoe, D. J. (2008) · Neural Development · doi:10.1186/1749-8104-3-15 · Cited by 210
Kupina, N. C., Detloff, M. R., Bobrowski, W. F., Snyder, B. J., & Hall, E. D. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00048-1 · Cited by 111
Lewén, A., Li, G. L., Olsson, Y., & Hillered, L. (1996) · Brain Research · doi:10.1016/0006-8993(96)00081-9 · Cited by 90 · cited 2×
“Although this loss of MAP-2 immunoreactivity is not always indicative of neuronal cell loss (Lewen et al. 1996; Folkerts 40 30 20 % D A B w ei gh t % D A B w ei gh t % D A B w ei gh t 10 Sham Sham Sham ** ** * ** *** *** ^^^ 0 40 50 30 20 10 0 30 20 10 0 Mild Moderate Injury level Severe Mild…”
BackgroundHarris, N. G., Mironova, Y. A., Hovda, D. A., & Sutton, R. L. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181cb5bee · Cited by 70
Cited by
Not just amyloid: physiological functions of the amyloid precursor protein family
Müller, U. C., Deller, T., & Korte, M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.29 · Cited by 634
Immunology of Relapse and Remission in Multiple Sclerosis
Steinman, L. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120227 · Cited by 330
A Greek Tragedy: The Growing Complexity of Alzheimer Amyloid Precursor Protein Proteolysis
Andrew, R. J., Kellett, K. A. B., Thinakaran, G., & Hooper, N. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.746032 · Cited by 173
“1 and 5 sAPP Induction of Akt cell survival pathway (71) Protection against neuronal damage caused by traumatic brain injury (72) Protection against synaptic dysfunction (73) and roles in synaptic plasticity (74) CTF Reduction of spine density and induction of synaptotoxicity (70) Possible role as a -secretase inhibit…”
Decourt, B., D’Souza, G. X., Shi, J., Ritter, A., Suazo, J., & Sabbagh, M. N. (2022) · Aging and disease · doi:10.14336/ad.2021.0529 · Cited by 69
Tan, V. T. Y., Mockett, B. G., Ohline, S. M., Parfitt, K. D., Wicky, H. E., Peppercorn, K., Schoderboeck, L., Yahaya, M. F. B., Tate, W. P., Hughes, S. M., et al. (2018) · Molecular Brain · doi:10.1186/s13041-018-0348-9 · Cited by 61
Metadata
- Authors
- Corrigan, F., Vink, R., Blumbergs, P. C., Masters, C. L., Cappai, R., & van den Heuvel, C.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2012-05-17
- Volume
- 122
- Issue
- 1
- Pages
- 208-220
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1602123250
- Cited by
- 75
- References
- 22
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.